What Causes Scleroderma? PDF Print E-mail
Monday, 13 September 2010 16:52
Collagen is a group of naturally occurring proteins, found exclusively in animals and especially in the flesh and connective tissues of mammals. It is the main component of connective tissue, and is the most abundant protein in mammals, constituting about 25% to 35% of the whole-body protein content. Beside connective tissue, collagen (in the form of elongated fibrils) is mostly found in fibrous tissues such as tendons and ligaments, and abundant in the cornea, cartilage, bones, blood vessels, the gut, and intervertebral discs.

The connective tissue is the material between the cells of the body that gives tissues form and strength. Fibrous in nature, it is produced by special cells called fibroblasts and made up of dozens of proteins, including collagen (a fibrous protein building block), proteoglycans (a group of proteins that maintain tissue stiffness), and glycoproteins (composed of a protein and a sugar).

Connective tissue also surrounds and supports many of the organs and structures within the body, including the skin, blood vessels, and nerves.

Similarly, many cells of the immune system are found in the connective tissue. In Scleroderma, autoimmunity leads to excessive production and accumulation of collagen in the skin and other connective tissues, causing hardening and scarring (fibrosis). Smaller blood vessels are also damaged, causing many of the complications associated with the disorder, including high blood pressure and the onset of Raynaud's.

Although doctors aren't sure what prompts this abnormal collagen production, the body's immune system plays a significant role. For reasons still unknown, the system turns against the body, attacking the cells (fibroblasts) that produce collagen. Collagen is usually produced in small amounts, but the attack prompts inflammation and the eventual overproduction of the collagen, which replaces normal tissue in the skin and other organs.

Some medical scientists, researchers, and experts assert that Scleroderma is caused by a number of inherited or genetic abnormalities or vulnerabilities, which were triggered by environmental factors, such as a virus, certain adhesive and coating materials, and organic solvents such as vinyl chloride or trichloroethylene. It should be noted however, that research is being conducted to verify these and similar connections.

According to Dr. Laura Hummers and Dr. Fred Wigley, several drugs are used that have in vitro (in the tissue culture) ability to reduce collagen production or to destabilize tissue collagen. The older medications in this category include colchicine, para-aminobenzoic acid (PABA), dimethyl sulfoxide, and D-penicillamine. Although there is evidence for and against the use of these agents, most experts are disappointed with them and believe that the benefit either does not exist or the drug is not potent enough to warrant its use.

The search for new drugs that alter the fibrotic reaction is probably one of the most active areas of Scleroderma research. Strategies include directly suppressing the fibroblast and its ability to make collagen, inhibiting the cytokines that activate the fibroblast, and the use of agents that might break down collagen faster and promote tissue remodeling.

For futher reading, we encourage you to visit some of the sources identified below. You can also login, to download Chapter 23 of Systemic Sclerosis, 2nd Edition written by Dr. Laura Hummers and Dr. Fred Wigley, in which the previous three paragraphs were taken, from the link provided below.

  • A.D.A.M (2009), “Scleroderma”, viewed online at http://nyti.ms/cntoNm
  • Health Grades Inc. (2010), “Causes of Scleroderma”, Wrong Diagnosis; viewed online at http://bit.ly/avwwlq
  • John Hopkins Scleroderma Center (2010), “Scleroderma Treatment Options”, viewed online at http://bit.ly/bCHCbg
  • Mayo Foundation (2010), “Scleroderma”, viewed online at http://bit.ly/9CBlAF
  • Science Daily (2005), “New Clues Into Causes of Scleroderma”, viewed online at http://bit.ly/bXHefF
  • Trafton, A. (2010), “Exposing collagen's double life”, MIT News; viewed online at http://bit.ly/cIkfTc
  • Wellsphere (2010), “Autoimmunity leads to excessive production of collagen in scleroderma”, Wellsphere; viewed online at http://bit.ly/bFhwYn
  • Wikipedia (2010), “Collagen”, viewed online at http://bit.ly/aqzwsH

More articles :

» Understanding The Female Bias For Autoimmune Diseases

The reasons why women are so much more commonly affected by autoimmune disease have largely remained a complex mystery. Now, however, researchers from the have identified a previously unknown type of B cell in aged female mice and in young...

» Air Pollution Linked to Autoimmune Diseases

Many people with environmental illnesses have an assortment of autoimmune diseases which scientists are linking to air pollution.Though genetic factors have been found for autoimmune diseases, this knowledge has not helped to prevent them. In fact,...

» New Study Shows Increased Risk Of Cancer In Scleroderma

patients have a 75% increased risk of cancer compared to the general population, a meta-analysis confirms, leading the authors to recommend screening in these patients.Patients were at particular risk of developing (RR 4.35) and haematological...

» Georgetown Study: Scleroderma Dramatically Under-diagnosed With Commercial Screening Method

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented...

» Glucosamine, Chondroitin and MSM as Alternative Therapies for Scleroderma

In an article titled, "Glucosamine, Chondroitin and MSM as Alternative Therapies for Scleroderma", Dr. Robert B. Buckingham, M.D., discussed three alternative medicines for treating the pain and the other features associated with . Here, we sought...

» A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis

T. W. van Hal, L. van Bon, and T. R. D. J. RadstakeReceived 20 May 2011; Revised 18 August 2011; Accepted 7 September 2011Systemic sclerosis (SSc) is typified by vascular alterations and immunological disturbances and fibrosis of the skin and...